Bridging the gap for lipid lowering therapy: plaque regression, coronary computed tomographic angiography, and imaging-guided personalized medicine

References

• Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2013;380:2197–2223.
   Web of Science ®Google Scholar
• Mozaffarian D, Benjamin EJ, Go AS, et al. Executive summary: heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation. 2016 Jan 26;133(4):447–454.
   Google Scholar
• Libby P. The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol. 2005;46:1225–1228.
   PubMed Web of Science ®Google Scholar
• Holmes C, Schulzer M, Mancini G. Angiographic results of lipid-lowering trials: a systematic review and meta-analysis. In: Cholesterol-lowering therapy: evaluation of clinical trial evidence(ed. SM Grundy). New York, NY: Marcel Dekker Inc; 2000. p. 191–220.
   Google Scholar
• Tsujita K, Sugiyama S, Sumida H, et al. Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial. J Am Coll Cardiol. 2015;66:495–507.
   PubMed Web of Science ®Google Scholar
• Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2008;372:1231–1239.
   PubMed Web of Science ®Google Scholar
• Kjekshus, J., Apetrei, E., Barrios, V. et al. Rosuvastatin in older patients with systolic heart failure. New England J Med. 2007;357:2248–2261.
   PubMed Web of Science ®Google Scholar
• Banach, M., Rizzo, M., Toth, P. P. et al. Statin intolerance–an attempt at a unified definition. Position paper from an international lipid expert panel. Arch Med Sci. 2015;11:1.
   PubMed Web of Science ®Google Scholar
• Tice JA, Ollendorf DA, Cunningham C, et al. PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value based price benchmarks. Institute for Clinical and Economic Review, Comparative Effectiveness Public Advisory Council; Boston (MA); 2015.
   Google Scholar
• Mora S, Wenger NK, Demicco DA, et al. Determinants of residual risk in secondary prevention patients treated with high-versus low-dose statin therapy the Treating to New Targets (TNT) study. Circulation. 2012;125:1979–1987.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Mizuno K, Nakaya N, et al. The relationship between the effect of pravastatin and risk factors for coronary heart disease in Japanese patients with hypercholesterolemia. Circ J. 2008;72:1576–1582.
   PubMed Web of Science ®Google Scholar
• Group, W.o.S.C.P.S. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation. 1998;97:1440–1445.
   PubMed Web of Science ®Google Scholar
• Peters BJ, Pett H, Klungel OH, et al. Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI. Atherosclerosis. 2011;217:458–464.
   PubMed Web of Science ®Google Scholar
• Kataoka Y, St John J, Wolski K, et al. Atheroma progression in hyporesponders to statin therapy. Arterioscler Thromb Vasc Biol. 2015;35:990–995.
   PubMed Web of Science ®Google Scholar
• Chasman DI, Posada D, Subrahmanyan L, et al. Pharmacogenetic study of statin therapy and cholesterol reduction. Jama. 2004;291:2821–2827.
   PubMed Web of Science ®Google Scholar
• Wannarong T, Parraga G, Buchanan D, et al. Progression of carotid plaque volume predicts cardiovascular events. Stroke. 2013;44:1859–1865.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging. 2010;3:1229–1236.
   PubMed Web of Science ®Google Scholar
• Kobashigawa JA, Tobis JM, Starling RC, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005;45:1532–1537.
   PubMed Web of Science ®Google Scholar
• Tuzcu EM, Kapadia SR, Sachar R, et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol. 2005;45:1538–1542.
   PubMed Web of Science ®Google Scholar
• Puri R, Wolski K, Uno K, et al. Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events. JACC Cardiovasc Interv. 2013;6:29–35.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Mora S, Rose L. Per cent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents. Eur Heart J. 2016;37:1373–1379.
   PubMed Web of Science ®Google Scholar
• von Birgelen C, Hartmann M, Mintz GS, et al. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. Circulation. 2003;108:2757–2762.
   PubMed Web of Science ®Google Scholar
• D’Ascenzo F, Agostoni P, Abbate A, et al. Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. Atherosclerosis. 2013;226:178–185.
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Hsu A, Wolski K, et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol. 2010;55:2399–2407.
   PubMed Web of Science ®Google Scholar
• Bayturan O, Kapadia S, Nicholls SJ, et al. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. J Am Coll Cardiol. 2010;55:2736–2742.
   PubMed Web of Science ®Google Scholar
• Puri R, Nissen SE, Nicholls SJ. Statin-induced coronary artery disease regression rates differ in men and women. Curr Opin Lipidol. 2015;26:276–281.
   PubMed Web of Science ®Google Scholar
• Hattori K, Ozaki Y, Ismail TF, et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter–IVUS. JACC Cardiovasc Imaging. 2012;5:169–177.
   PubMed Web of Science ®Google Scholar
• Habara M, Nasu K, Terashima M, et al. Impact on optical coherence tomographic coronary findings of fluvastatin alone versus fluvastatin+ ezetimibe. Am J Cardiol. 2014;113:580–587.
   PubMed Web of Science ®Google Scholar
• Kini AS, Baber U, Kovacic JC, et al. Changes in plaque lipid content after short-term intensive versus standard statin therapyThe YELLOW trial (Reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol. 2013;62:21–29.
   PubMed Web of Science ®Google Scholar
• Takano M, Mizuno K, Yokoyama S, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy. J Am Coll Cardiol. 2003;42:680–686.
   PubMed Web of Science ®Google Scholar
• Kodama K, Komatsu S, Ueda Y, et al. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound-the TOGETHAR trial. Circ J. 2010;74:1922–1928.
   PubMed Web of Science ®Google Scholar
• Takayama T, Hiro T, Ueda Y, et al. Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHAR trial with intravascular ultrasound and coronary angioscopy. Heart Vessels. 2015;30:169–176.
   PubMed Web of Science ®Google Scholar
• Puri R, Libby P, Nissen SE, et al. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. Eur Heart J Cardiovasc Imaging. 2014;15:380–388.
   PubMed Web of Science ®Google Scholar
• Räber L, Taniwaki M, Zaugg S, et al. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Eur Heart J. 2015;36:490–500.
   PubMed Web of Science ®Google Scholar
• Paixao AR, Ayers CR, El Sabbagh A, et al. Coronary artery calcium improves risk classification in younger populations. JACC Cardiovasc Imaging. 2015;8:1285–1293.
   PubMed Web of Science ®Google Scholar
• Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New England J Med. 2008;358:1336–1345.
   PubMed Web of Science ®Google Scholar
• Nicoll R, Wiklund U, Zhao Y, et al. The coronary calcium score is a more accurate predictor of significant coronary stenosis than conventional risk factors in symptomatic patients: euro-CCAD study. Int J Cardiol. 2016;207:13–19.
   PubMed Web of Science ®Google Scholar
• Erbel R, Möhlenkamp S, Moebus S, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol. 2010;56:1397–1406.
   PubMed Web of Science ®Google Scholar
• Hoffmann U, Massaro JM, D’Agostino RB, et al. Cardiovascular event prediction and risk reclassification by coronary, aortic, and valvular calcification in the framingham heart study. J Am Heart Assoc. 2016;5:e003144.
   PubMed Web of Science ®Google Scholar
• McClelland RL, Jorgensen NW, Budoff M, et al. 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J Am Coll Cardiol. 2015;66:1643–1653.
   PubMed Web of Science ®Google Scholar
• Blaha, M.J., Cainzos-Achirica, M., Greenland, P. et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study Of Atherosclerosis (MESA). Circulation CIRCULATIONAHA. 2016;115:018524.
   Google Scholar
• Erbel R, Lehmann N, Churzidse S, et al. Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) study. Eur Heart J. 2014;35:2960–2971.
   PubMed Web of Science ®Google Scholar
• Priester TC, Litwin SE. Measuring progression of coronary atherosclerosis with computed tomography: searching for clarity among shades of gray. J Cardiovasc Comput Tomogr. 2009;3:S81–S90.
   PubMedGoogle Scholar
• Nicholls SJ, Tuzcu EM, Wolski K, et al. Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol. 2007;49:263–270.
   PubMed Web of Science ®Google Scholar
• Kwan AC, May HT, Cater G, et al. Coronary artery plaque volume and obesity in patients with diabetes: the factor-64 study. Radiology. 2014;272:690–699.
   PubMed Web of Science ®Google Scholar
• Kristensen TS, Kofoed KF, Kühl JT, et al. Prognostic implications of nonobstructive coronary plaques in patients with non–ST-segment elevation myocardial infarction: a multidetector computed tomography study. J Am Coll Cardiol. 2011;58:502–509.
   PubMed Web of Science ®Google Scholar
• Motoyama S, Ito H, Sarai M, et al. Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol. 2015;66:337–346.
   PubMed Web of Science ®Google Scholar
• Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. New England J Med. 2008;359:2324–2336.
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Nakazato R, Mancini GBJ, et al. CT angiography for the prediction of hemodynamic significance in intermediate and severe lesions: head-to-head comparison with quantitative coronary angiography using fractional flow reserve as the reference standard. JACC Cardiovasc Imaging. 2016;9:559–564.
   PubMed Web of Science ®Google Scholar
• Rochitte CE, George RT, Chen MY, et al. Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study. Eur Heart J. 2014;35:1120–1130.
   PubMed Web of Science ®Google Scholar
• Nørgaard BL, Leipsic J, Gaur S, et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of coronary blood flow using CT angiography: next steps). J Am Coll Cardiol. 2014;63:1145–1155.
   PubMed Web of Science ®Google Scholar
• Taylor AJ, Cerqueira M, Hodgson JM, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American college of cardiology foundation appropriate use criteria task force, the society of cardiovascular computed tomography, the American college of radiology, the American heart association, the American society of echocardiography, the American society of nuclear cardiology, the north American society for cardiovascular imaging, the society for cardiovascular angiography and interventions, and the society for cardiovascular magnetic resonance. J Am Coll Cardiol. 2010;56:1864–1894.
   PubMed Web of Science ®Google Scholar
• Chen MY, Shanbhag SM, Arai AE, et al. Submillisievert median radiation dose for coronary angiography with a second-generation 320–detector row CT scanner in 107 consecutive patients. Radiology. 2013;267:76–85.
   PubMed Web of Science ®Google Scholar
• Schuhbaeck A, Dey D, Otaki Y, et al. Interscan reproducibility of quantitative coronary plaque volume and composition from CT coronary angiography using an automated method. Eur Radiol. 2014;24:2300–2308.
   PubMed Web of Science ®Google Scholar
• Øvrehus KA, Schuhbaeck A, Marwan M, et al. Reproducibility of semi-automatic coronary plaque quantification in coronary CT angiography with sub-mSv radiation dose. J Cardiovasc Comput Tomogr. 2015;10:114–120.
   PubMed Web of Science ®Google Scholar
• Bruining N, Roelandt JRTC, Palumbo A, et al. Reproducible coronary plaque quantification by multislice computed tomography. Catheter Cardiovasc Interv. 2007;69:857–865.
   PubMed Web of Science ®Google Scholar
• Park H-B, Lee BK, Shin S, et al. Clinical feasibility of 3D automated coronary atherosclerotic plaque quantification algorithm on coronary computed tomography angiography: comparison with intravascular ultrasound. Eur Radiol. 2015;25:3073–3083.
   PubMed Web of Science ®Google Scholar
• Symons R, Morris J, Wu CO, et al. Coronary CT angiography: variability of CT scanners and readers for measurement of plaque volume. Radiology. 2016 In Press;281:737–748.
   PubMed Web of Science ®Google Scholar
• Bruining N, Roelandt JRTC, Verheye S, et al. Compositional volumetry of non-calcified coronary plaques by multislice computed tomography: an ex vivo feasibility study. EuroIntervention. 2009;5:558–564.
   PubMed Web of Science ®Google Scholar
• Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54:49–57.
   PubMed Web of Science ®Google Scholar
• Pflederer T, Marwan M, Schepis T, et al. Characterization of culprit lesions in acute coronary syndromes using coronary dual-source CT angiography. Atherosclerosis. 2010;211:437–444.
   PubMed Web of Science ®Google Scholar
• Otsuka K, Fukuda S, Tanaka A, et al. Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome. JACC Cardiovasc Imaging. 2013;6:448–457.
   PubMed Web of Science ®Google Scholar
• Puchner SB, Liu T, Mayrhofer T, et al. High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll Cardiol. 2014;64:684–692.
   PubMed Web of Science ®Google Scholar
• Sandfort V, Lima JA, Bluemke DA. Noninvasive imaging of atherosclerotic plaque progression status of coronary computed tomography angiography. Circ Cardiovasc Imaging. 2015;8:e003316.
   PubMed Web of Science ®Google Scholar
• Rodriguez K, Kwan AC, Lai S, et al. Coronary plaque burden at coronary CT angiography in asymptomatic men and women. Radiology. 2015;277:73–80.
   PubMed Web of Science ®Google Scholar
• Gitsioudis G, Schüssler A, Nagy E, et al. Combined assessment of high-sensitivity troponin t and noninvasive coronary plaque composition for the prediction of cardiac outcomes. Radiology. 2015;276:73–81.
   PubMed Web of Science ®Google Scholar
• Schmid M, Achenbach S, Ropers D, et al. Assessment of changes in non-calcified atherosclerotic plaque volume in the left main and left anterior descending coronary arteries over time by 64-slice computed tomography. Am J Cardiol. 2008;101:579–584.
   PubMed Web of Science ®Google Scholar
• Papadopoulou S-L, Neefjes LA, Garcia-Garcia HM, et al. Natural history of coronary atherosclerosis by multislice computed tomography. JACC Cardiovasc Imaging. 2012;5:S28–S37.
   PubMed Web of Science ®Google Scholar
• Ayad SW, ElSharkawy EM, ElTahan SM, et al. The role of 64/128-slice multidetector computed tomography to assess the progression of coronary atherosclerosis. Clin Med Insights Cardiol. 2015;9:47.
   PubMedGoogle Scholar
• Ito H, Motoyama S, Sarai M, et al. Characteristics of plaque progression detected by serial coronary computed tomography angiography. Heart Vessels. 2014;29:743–749.
   PubMed Web of Science ®Google Scholar
• Inoue K, Motoyama S, Sarai M, et al. Serial coronary CT angiography–verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging. 2010;3:691–698.
   PubMed Web of Science ®Google Scholar
• Zeb I, Li D, Nasir K, et al. Effect of statin treatment on coronary plaque progression–a serial coronary CT angiography study. Atherosclerosis. 2013;231:198–204.
   PubMed Web of Science ®Google Scholar
• Shin S, Park HB, Chang HJ, et al. Impact of intensive LDL cholesterol lowering on coronary artery atherosclerosis progression: a serial CT angiography study. JACC: Cardiovasc Imaging. 2017 Apr 30;10(4):437–446.
   Google Scholar
• Lo J, Lu MT, Ihenachor EJ, et al. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. The Lancet HIV. 2015;2:e52–e63.
   PubMed Web of Science ®Google Scholar
• Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. New England J Med. 2011;364:226–235.
   PubMed Web of Science ®Google Scholar
• Lee S-E, Chang H-J, Rizvi A, et al. Rationale and design of the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry: A comprehensive exploration of plaque progression and its impact on clinical outcomes from a multicenter serial coronary computed tomographic angiography study. Am Heart J. 2016;182:72–79.
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63:2889–2934.
   PubMed Web of Science ®Google Scholar